Results 91 to 100 of about 22,007 (218)
Objectives Atherosclerosis is the underlying pathology of cardiovascular disease (CVD), including hypertension. Unfortunately, the association between the atherogenic index of plasma (AIP) and hypertension has not been reported in a large‐scale middle ...
Xiao Chen +3 more
doaj +1 more source
Abstract figure legend We examined the interaction effect of ovarian hormones and APOE genotype on cerebrovascular and mitochondrial function. Our data revealed that APOEε3 mice that were ovariectomized exhibited impaired endothelial function and greater oxidative stress and inflammation compared to sham controls.
Mackenzie N. Kehmeier +9 more
wiley +1 more source
Background The Atherogenic Index of Plasma (AIP) is a novel logarithmic index that combines fasting triglyceride and high-density lipoprotein cholesterol (HDL-C) concentrations and is associated with the burden of atherosclerosis.
Zhenyan Wu +5 more
doaj +1 more source
Pulsed electric field (PEF) processing qualitatively reshapes the phytochemical profile of red beet extracts, resulting in enhanced endothelial bioefficacy. Compared with conventional extraction, PEF‐treated extracts more effectively restore nitric oxide signaling, suppress endothelial inflammation, and normalize vascular structure in high‐fat diet ...
Eunju Jang +8 more
wiley +1 more source
Hypericum perforatum ethanolic extract (HPEE) at the levels of 0, 150, 300 and 450 mg/kg were used and dietary treatments did not affect growth performance including feed intake, body weight and feed conversion ratio. The HPPE reduced the abdominal fat and improved meat quality in broilers.
Hojjat Seraji‐Kopkan +3 more
wiley +1 more source
Background: Patients with type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular disease, largely driven by atherogenic dyslipidaemia.
Samiya Begum Ibrahim +3 more
doaj +1 more source
Atherogenic index of plasma identifies subjects with severe liver steatosis
Abstract The Atherogenic Index of Plasma (AIP), calculated by log (Triglycerides/HDL-C), has been proposed as a marker of atherogenic and cardiovascular risk. Atherosclerosis and Metabolic Dysfunction—Associated Steatotic Liver Disease (MASLD) share some pathogenic features and may be considered clinical manifestations of Metabolic Syndrome ...
Carlo De Matteis +7 more
openaire +3 more sources
ABSTRACT Aims Metabolic dysfunction‐associated steatohepatitis (MASH) is a leading cause of cirrhosis. NIS2+ is a recently approved serum‐based test combining two biomarkers (miR‐34a‐5p and YKL‐40) to identify at‐risk MASH (i.e., MASH and significant fibrosis). Objective To assess the prevalence of at‐risk MASH by NIS2+ in individuals from primary care
Srilaxmi Kalavalapalli +12 more
wiley +1 more source
Context‐Dependent Effects of Apolipoprotein A2 on Lipid Metabolism and Atherogenesis
Proposed model of the pro‐atherogenic role of APOA2 in dyslipidemia. Under conditions of dyslipidemia (ldlr−/− and apoe−/− mice), APOA2 promotes a reduction in VLDL through its conversion to LDL via an LDLR‐independent pathway. LDL is then deposited to the aorta and aortic root. In the ldlr−/− mice, the presence of APOE may mitigate the rate of VLDL to
Evangelia Zvintzou +9 more
wiley +1 more source
Positive and Negative Cardiovascular Effects of JAK Inhibitors in Inflammation
Chronic inflammation, characteristic of many autoimmune diseases, such as rheumatoid arthritis (RA), or myeloproliferative neoplasms (MPNs), is an independent driver of accelerated cardiovascular (CV) risk, primarily through proinflammatory cytokines that induce atherosclerosis and endothelial dysfunction.
Aliki Zavoriti, Pierre Miossec
wiley +1 more source

